Abstract 2827: Discovery of AP26113, a potent, orally active inhibitor of anaplastic lymphoma kinase and clinically relevant mutants
2016 ◽
Vol 59
(10)
◽
pp. 4948-4964
◽
Keyword(s):
2020 ◽
Vol 63
(22)
◽
pp. 13994-14016
2011 ◽
2011 ◽
Vol 11
(3)
◽
pp. 670-679
◽
2012 ◽
Vol 20
(3)
◽
pp. 1271-1280
◽
2012 ◽
Vol 17
(2)
◽
pp. 123-143
◽